Incyte Corporation
Clinical trials sponsored by Incyte Corporation, explained in plain language.
-
New combo therapy shows promise for tough lung cancer
Disease control CompletedThis study tested a new drug combination (itacitinib plus osimertinib) in 59 adults with advanced non-small cell lung cancer that has a specific genetic change (EGFR mutation). The goal was to see if the combination is safe and helps shrink tumors. Participants received both drug…
Phase: PHASE1, PHASE2 • Sponsor: Incyte Corporation • Aim: Disease control
Last updated Apr 26, 2026 19:37 UTC
-
Tiny needles, big potential: new skin fluid collection method tested
Knowledge-focused CompletedThis study tested a new microneedle patch to collect fluid from the skin of 20 healthy volunteers and people with eczema (atopic dermatitis). The goal was to see how much fluid could be collected and how well it was tolerated. This early-stage research aims to improve how we samp…
Sponsor: Incyte Corporation • Aim: Knowledge-focused
Last updated May 04, 2026 16:29 UTC